MedPath

Propofol and etomidate. Are they also safe for patients with Brugada-Syndrome?

Conditions
Brugada-Syndrome, Propofol, Etomidate, Arrhythmia,
Registration Number
NL-OMON24665
Lead Sponsor
niversitair Ziekenhuis BrusselLaarbeeklaan 1011090 JetteBelgium
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
78
Inclusion Criteria

All paediatric and adult patients that have been screened for BrS and were found positive before or after the Ajmaline-test are included.

Exclusion Criteria

1. Patients with a known allergy for soya are excluded from the study;

2. Patients with a supressed immune-status are excluded from the study;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ECG changes. ST elevation of 1 or more mm which is described as type I, or coved.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath